Icodextrin in PD patients

Publisher： John Wiley & Sons Inc

E-ISSN： 1440-1797|20|3|161-167

ISSN： 1320-5358

Source： NEPHROLOGY, Vol.20, Iss.3, 2015-03, pp. : 161-167

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Intraperitoneal Heparin Ameliorates the Systemic Inflammatory Response in PD Patients

By  

Nephron Clin Pract, Vol. 100, Iss. 4, 2005-04 ,pp. : c105-c110

Karger

Access to resources Recommend Favorite

Treatment of PD‐1−/− mice with amodiaquine and anti‐CTLA4 leads to liver injury similar to idiosyncratic liver injury in patients

By  

HEPATOLOGY, Vol. 61, Iss. 4, 2015-04 ,pp. : 1332-1342

John Wiley & Sons Inc

Access to resources Recommend Favorite

Impact of PD-L1 Expression in Patients with Surgically Resected Non-Small-Cell Lung Cancer

By  

Oncology, Vol. 92, Iss. 5, 2017-02 ,pp. : 283-290

Karger

Access to resources Recommend Favorite

Co‐inhibitory profile and cytotoxicity of CD57+PD‐1– T cells in end‐stage renal disease patients

By  

CLINICAL & EXPERIMENTAL IMMUNOLOGY, Vol. 191, Iss. 3, 2018-03 ,pp. : 363-372

John Wiley & Sons Inc

Access to resources Recommend Favorite

PD‐1 inhibitor‐related pneumonitis in lymphoma patients treated with single‐agent pembrolizumab therapy

By  

BRITISH JOURNAL OF HAEMATOLOGY, Vol. 180, Iss. 5, 2018-03 ,pp. : 752-755

John Wiley & Sons Inc

Access to resources Recommend Favorite